Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 422

1.

Population-based cohort study assessing the efficacy of cervical cytology (Pap smear) and human papillomavirus (HPV) testing as modalities for cervical cancer screening.

Morisada T, Saika K, Saito E, Kono K, Saito H, Aoki D.

Jpn J Clin Oncol. 2018 May 1;48(5):495-498. doi: 10.1093/jjco/hyy025.

PMID:
30535331
2.

Australian women's cervical cancer screening attendance as a function of screening barriers and facilitators.

Brown RF, Muller TR, Olsen A.

Soc Sci Med. 2018 Nov 28;220:396-402. doi: 10.1016/j.socscimed.2018.11.038. [Epub ahead of print]

PMID:
30529797
3.

Results of a Pilot Study of a Mail-Based HPV Self-Testing Program for Underscreened Women from Appalachian Ohio.

Reiter PL, Shoben AB, McDonough D, Ruffin MT, Steinau M, Unger ER, Paskett ED, Katz ML.

Sex Transm Dis. 2018 Nov 19. doi: 10.1097/OLQ.0000000000000944. [Epub ahead of print]

PMID:
30461597
4.

Preferences of Underserved Chilean Women on a Mobile Technology Intervention for Cervical Cancer Screening: Qualitative Study.

Soto M, Martinez-Gutierrez J, Momany M, Capurro D, Ciampi Spode F, Cea E, Mergudich T, Puschel K.

JMIR Mhealth Uhealth. 2018 Nov 20;6(11):e196. doi: 10.2196/mhealth.9494.

5.

Distribution of cervical abnormalities detected by visual inspection with acetic acid in Swaziland, 2011-2014: A retrospective study.

Ginindza TG, Almonte M, Dlamini X, Sartorius B.

Afr J Prim Health Care Fam Med. 2018 Oct 18;10(1):e1-e7. doi: 10.4102/phcfm.v10i1.1773.

6.

Cervical Cancer Screening Behaviors and Perceptions of Medical Mistrust among Rural Black and White Women.

Hall MB, Vos P, Bess JJ, Reburn KL, Locklear GD, McAlister J, Bell RA.

J Health Care Poor Underserved. 2018;29(4):1368-1385. doi: 10.1353/hpu.2018.0101.

PMID:
30449752
7.

Does the 'equal management of equal risks' model cause overtreatment in patients with positive cervical cytology results for ASCUS/non-HPV16/18 oncogenic types?

Karaca İ, Öztürk M, Comba C, Demirayak G, Erdoğan ŞV, Hoşgören M, Özdemir İA.

Diagn Cytopathol. 2018 Nov 16. doi: 10.1002/dc.24029. [Epub ahead of print]

PMID:
30444320
8.

Utilization of Pap testing among women living with HIV enrolled in primary care in Baltimore, Maryland: A 10-year longitudinal study, 2005-2014.

Peprah S, Coleman JS, Rositch AF, Vanden Bussche CJ, Moore R, D'Souza G.

Papillomavirus Res. 2018 Dec;6:52-57. doi: 10.1016/j.pvr.2018.10.002. Epub 2018 Oct 25.

9.

Cervical Cancer Awareness and Practice of Pap Smear Test Among Women with Gynecological problems.

Thapa M.

JNMA J Nepal Med Assoc. 2018 Mar-Apr;56(211):654-657.

PMID:
30381758
10.

Cervical Cancer Screening Research in the PROSPR I Consortium: Rationale, Methods, and Baseline Findings from a U.S. Cohort.

Kamineni A, Tiro JA, Beaber EF, Silverberg MJ, Wheeler CM, Chao CR, Chubak J, Skinner CS, Corley DA, Kim JJ, Balasubramanian BA, Doria-Rose VP; PROSPR consortium.

Int J Cancer. 2018 Oct 24. doi: 10.1002/ijc.31940. [Epub ahead of print]

PMID:
30353911
11.

Chronic comorbidities and cervical cancer screening and adherence among US-born and foreign-born women.

Cofie LE, Hirth JM, Wong R.

Cancer Causes Control. 2018 Nov;29(11):1105-1113. doi: 10.1007/s10552-018-1084-2. Epub 2018 Oct 23.

PMID:
30353481
12.

Use of Preventive Health Services Among Cancer Survivors in the U.S.

Gupta S, Cole AP, Marchese M, Wang Y, Speed JM, Fletcher SA, Nabi J, Berg S, Lipsitz SR, Choueiri TK, Chang SL, Kibel AS, Uhlig A, Trinh QD.

Am J Prev Med. 2018 Dec;55(6):830-838. doi: 10.1016/j.amepre.2018.07.021. Epub 2018 Oct 21.

PMID:
30352719
13.

A systematic review of the effectiveness of health education interventions to increase cervical cancer screening uptake.

Agide FD, Garmaroudi G, Sadeghi R, Shakibazadeh E, Yaseri M, Koricha ZB, Tigabu BM.

Eur J Public Health. 2018 Dec 1;28(6):1156-1162. doi: 10.1093/eurpub/cky197.

PMID:
30346504
14.

Costs and cost-effectiveness of LEEP versus cryotherapy for treating cervical dysplasia among HIV-positive women in Johannesburg, South Africa.

Lince-Deroche N, van Rensburg C, Roseleur J, Sanusi B, Phiri J, Michelow P, Smith JS, Firnhaber C.

PLoS One. 2018 Oct 11;13(10):e0203921. doi: 10.1371/journal.pone.0203921. eCollection 2018.

15.

Acceptance of Cervical Cancer Screening and its Correlates Among Women of a Peri-Urban High-Density Residential Area in Ndola, Zambia.

Kabalika C, Mulenga D, Mazaba ML, Siziya S.

Int J MCH AIDS. 2018;7(1):17-27. doi: 10.21106/ijma.223.

16.

CervixCheck: A Spiritually-Based Text Messaging Intervention to Promote Cervical Cancer Awareness and Pap Test Screening Intention among African-American Women.

Le D, Holt CL.

J Health Commun. 2018;23(9):842-853. doi: 10.1080/10810730.2018.1528317. Epub 2018 Oct 9.

PMID:
30300091
17.

Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Melnikow J, Henderson JT, Burda BU, Senger CA, Durbin S, Soulsby MA.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Aug.

18.

Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening.

Wang HY, Kim H, Park KH.

Int J Infect Dis. 2018 Sep 21;78:22-30. doi: 10.1016/j.ijid.2018.09.014. [Epub ahead of print]

19.

Evaluation of the risk of cervical cancer in patients with Multiple Sclerosis treated with cytotoxic agents: A cohort study.

Doosti R, Togha M, Moghadasi AN, Aghsaie A, Azimi AR, Khorramnia S, Moinfar Z, Ensani F, Harirchian MH, Minagar A, Sahraian MA.

Iran J Neurol. 2018 Apr 4;17(2):64-70.

20.

Cervical Cancer Screening Every 5 Years OK.

[No authors listed]

Cancer Discov. 2018 Oct;8(10):1204. doi: 10.1158/2159-8290.CD-NB2018-118. Epub 2018 Sep 11.

PMID:
30206109

Supplemental Content

Loading ...
Support Center